Pathways

Uncovering the Commercial Opportunity of Innovative Research

In Pathways, Decision Resources applies its acclaimed clinical and commercial analysis to the early stages of scientific exploration. We focus on cutting-edge research and development and explore the new therapeutic targets and mechanisms that may result from these novel efforts. In focusing our analysis on novel cellular and molecular pathways, we deliver unparalleled coverage of breakthrough technologies that have the potential to influence the therapeutic markets of tomorrow.

Our information and analysis are built upon exhaustive review of the clinical literature and interviews with thought-leading physicians and researchers. Our findings are delivered in comprehensive yet accessible reports that analyze:

• Key therapeutic targets
• Areas of opportunity
• Challenges to heed
• Lessons learned from early research
• Commercial impact of drugs in development

In addition, each report reviews and assesses compounds in development across therapeutic areas, identifying the cross-indication potential of new compounds and research programs.

Each Pathways report describes novel molecular and cellular targets and assesses the potential of compounds in development for these targets. We undertake an in-depth review of the literature and solicit the opinions of experts to provide comprehensive coverage of key issues.

In addition, we identify the indications that are likely to be targeted with these new mechanisms and technologies, and assess how adequately clinical needs will be met within those indications. The commercial opportunity associated with each indication is weighed by reviewing population size, treatment issues, current market value, and the ability of the novel therapies to compete with traditional therapeutic approaches.

View our Pathways reports